Standardized guidelines for response assessment are needed to ensure comparability among clinical trials in non-Hodgkin's lymphomas (NHL). To achieve this, two meetings were convened among United States and international lymphoma experts representing medical hematology/oncology, radiology, radiation oncology, and pathology to review currently used response definitions and to develop a uniform set of criteria for assessing response in clinical trials. The criteria that were developed include anatomic definitions of response, with normal lymph node size after treatment of 1.5 cm in the longest transverse diameter by computer-assisted tomography scan. A designation of complete response/unconfirmed was adopted to include patients with a greater than 75% reduction in tumor size after therapy but with a residual mass, to include patients-especially those with large-cell NHL-who may not have residual disease. Single-photon emission computed tomography gallium scans are encouraged as a valuable adjunct to assessment of patients with large-cell NHL, but such scans require appropriate expertise. Flow cytometric, cytogenetic, and molecular studies are not currently included in response definitions. Response rates may be the most important objective in phase II trials where the activity of a new agent is important and may provide support for approval by regulatory agencies. However, the goals of most phase III trials are to identify therapies that will prolong the progression-free survival, if not the overall survival, of the treated patients. We hope that these guidelines will serve to improve communication among investigators and comparability among clinical trials until clinically relevant laboratory and imaging studies are identified and become more widely available.

Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas

Members of the Fleischner Society compiled a glossary of terms for thoracic imaging that replaces previous glossaries published in 1984 and 1996 for thoracic radiography and computed tomography (CT), respectively. The need to update the previous versions came from the recognition that new words have emerged, others have become obsolete, and the meaning of some terms has changed. Brief descriptions of some diseases are included, and pictorial examples (chest radiographs and CT scans) are provided for the majority of terms.

/pdf/fleischner-society-glossary-of-terms-for-thoracic-imaging-33j963qnls.pdf

Fleischner Society: Glossary of Terms for Thoracic Imaging

Objective: The aim was to formulate clinical practice guidelines for pheochromocytoma and paraganglioma (PPGL). Participants: The Task Force included a chair selected by the Endocrine Society Clinical Guidelines Subcommittee (CGS), seven experts in the field, and a methodologist. The authors received no corporate funding or remuneration. Evidence: This evidence-based guideline was developed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to describe both the strength of recommendations and the quality of evidence. The Task Force reviewed primary evidence and commissioned two additional systematic reviews. Consensus Process: One group meeting, several conference calls, and e-mail communications enabled consensus. Committees and members of the Endocrine Society, European Society of Endocrinology, and Americal Association for Clinical Chemistry reviewed drafts of the guidelines. Conclusions: The Task Force recommends that initial biochemical testing for PPGLs shou...

/pdf/pheochromocytoma-and-paraganglioma-an-endocrine-society-4ij7m1t7fo.pdf

Pheochromocytoma and paraganglioma: An endocrine society clinical practice guideline

结节病易误诊,据王洪武等~([1])收集国内18篇关于此病误诊的文献,误诊率高达63.2%,当然有误诊就会有误治,如孙永昌等~([2])报道26例结节病在影像学检查诊断的第一印象中拟诊结核5例,其中就有2例完成规范的抗结核治疗,为此应引起临床对本病诊治的重视。

Sarcoidosis

https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(14)61375-1.pdf

Cushing's syndrome

CT was used to investigate the number and size of normal mediastinal lymph nodes at 11 intrathoracic nodal stations defined by the American Thoracic Society lymph-node mapping scheme. Nodal size was measured both as short- and long-axis diameters in the transverse plane. Findings for 56 patients show the largest normal mediastinal nodes to be in the subcarinal and right tracheobronchial regions. Upper paratracheal nodes were smaller than lower paratracheal or tracheobronchial nodes, and right-sided tracheobronchial nodes were larger than left-sided ones. From the distributions of node sizes, thresholds were set above which nodes in any region might be considered enlarged. These thresholds, in agreement with a prior investigation of patients with lung cancer, suggest 1.0 cm as the upper limit of normal for the short axis of a mediastinal node in the transverse plane.

https://www.ajronline.org/doi/pdfplus/10.2214/ajr.144.2.261

Normal mediastinal lymph nodes: number and size according to American Thoracic Society mapping.

To ascertain the magnetic resonance (MR) imaging characteristics of pheochromocytomas and paragangliomas and to compare MR with computed tomography (CT) and iodine-131 metaiodobenzylguanidine (I-131 MIBG), 19 patients (18 with pheochromocytomas, one with a paraganglioma) were studied. The 18 patients with pheochromocytomas had had positive findings with I-131 MIBG scintigraphy. Abdominal pheochromocytomas were generally hypointense compared with normal liver on T1-weighted MR images and extremely hyperintense on T2-weighted MR images. MR imaging was preferable to CT in the evaluation of primary pheochromocytomas due to superior tissue characterization, particularly in the patient with hypertension and borderline catecholamine levels. For patients with recurrent or metastatic disease, the data suggest that I-131 MIBG scintigraphy is the examination of choice.

Pheochromocytoma and paraganglioma: comparison of MR imaging with CT and I-131 MIBG scintigraphy.

Using a superconducting magnet operating at 0.35 T, the authors investigated the adrenal tissue characterization potential of magnetic resonance (MR) in 28 patients with 33 adrenal masses. There were 13 adrenal adenomas (12 non-hyperfunctioning, one aldosteronoma), nine adrenal metastases, four pheochromocytomas, two neuroblastomas, two adrenal lymphomas, two myelolipomas, and one adrenal cortical carcinoma. Spin-echo pulse sequences were obtained at TR 0.5, 2.0 sec and TE 28, 56 msec. Both qualitative (visual assessment) and quantitative (absolute signal intensity, intensity ratios, T1, T2) data were used for tissue characterization. The results suggest that non-hyperfunctioning adrenal adenomas can be distinguished from non-adenomas using both qualitative and quantitative data: 16/19 non-adenomas were visually hyperintense compared with liver at TR 2.0 sec, TE 56 msec, while none of the non-hyperfunctioning adenomas was relatively hyperintense at any pulse sequence used. Of the quantitative data, the in...

Adrenal tissue characterization using MR imaging.

The computed tomographic appearance of the normal and abnormal thymus and its age-related changes have been described. However, there is little quantitative data regarding thymic morphology at the extremes of age and the value of thymic measurements, in particular thickness, to recognize thymic abnormality. Using computed tomography the thymic morphology in 309 normal patients was analyzed retrospectively, examining its appearance at the extremes of age and measuring its dimensions for comparison with similar data in 23 patients with clinically or surgically proven thymic abnormality. The study confirmed the previously reported age-related growth and subsequent involution of the normal thymus. In more than half the patients beyond the age of 40, total fatty involution of the gland occurred. When present, residual thymic tissue usually assumed a small, linear, oval, or round shape and did not produce focal alterations in the lateral mediastinal contour. Comparison of normal and abnormal glands suggests that thymic shape reliably separates normal from abnormal glands. In particular, multilobularity was never a feature of the normal gland at any age but was seen only in patients with thymic abnormality. Logarithms of the anteroposterior, craniocaudal, and transverse dimensions as well as thymic thickness were plotted against age to determine the value of quantitative measurements in detecting thymic abnormality. While thymic thickness and the logarithm of the product of transverse dimension and thickness were sensitive indicators of thymic abnormality, these were not necessary for accurate recognition of abnormality.

The thymus: reexamination of age-related changes in size and shape.

Computed tomography was used to evaluate the mediastinum preoperatively in 60 patients with non-small cell lung cancer; 49 of these patients had thorough surgical-pathologic determination of mediastinal node status. Mediastinal lymph nodes were located by CT using the node-mapping scheme suggested by the American Thoracic Society and were considered abnormal when larger than 100 mm2 in cross-sectional area. The sensitivity of CT was 95% in detecting malignant mediastinal adenopathy; however, specificity was only 64%. Receiver operating characteristic (ROC) curve analysis showed that the optimal size criterion for diagnosing malignant mediastinal adenopathy is 1.0-1.5 cm when the short axis of a node is measured. CT staging of the mediastinum in patients with non-small cell lung cancer is clinically useful; negative mediastinal CT makes mediastinoscopy unnecessary, whereas positive CT should lead to biopsy of the enlarged node.

Gary M. Glazer

Papers

Normal mediastinal lymph nodes: number and size according to American Thoracic Society mapping.

Pheochromocytoma and paraganglioma: comparison of MR imaging with CT and I-131 MIBG scintigraphy.

Adrenal tissue characterization using MR imaging.

The thymus: reexamination of age-related changes in size and shape.

The mediastinum in non-small cell lung cancer: CT-surgical correlation